These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 2974746)
41. A mechanism underlying dopamine D1 and D2 receptor-mediated inhibition of dopaminergic neurones in the ventral tegmental area in vitro. Momiyama T; Todo N; Sasa M Br J Pharmacol; 1993 Aug; 109(4):933-40. PubMed ID: 8104652 [TBL] [Abstract][Full Text] [Related]
42. Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. Lacey MG; Mercuri NB; North RA J Physiol; 1987 Nov; 392():397-416. PubMed ID: 2451725 [TBL] [Abstract][Full Text] [Related]
43. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation. Reyneke L; Russell VA; Taljaard JJ Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481 [TBL] [Abstract][Full Text] [Related]
44. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor. Martin JR; Beinfeld MC; Wang RY Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613 [TBL] [Abstract][Full Text] [Related]
45. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation. Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601 [TBL] [Abstract][Full Text] [Related]
46. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum. Battaglia G; Norman AB; Hess EJ; Creese I Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659 [TBL] [Abstract][Full Text] [Related]
47. D2- but not D1-dopamine receptors are involved in the inhibitory control of alpha-melanocyte-stimulating hormone release from the rat hypothalamus. Tiligada E; Wilson JF Exp Brain Res; 1989; 74(3):645-8. PubMed ID: 2540019 [TBL] [Abstract][Full Text] [Related]
48. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
49. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. Levant B; Grigoriadis DE; DeSouza EB J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154 [TBL] [Abstract][Full Text] [Related]
50. ACTH-(1-24) enhances the electrically stimulated release of [3H]dopamine from rat septal slices via a dopamine D2 receptor-independent mechanism. Florijn WJ; Versteeg DH Brain Res; 1989 Aug; 494(2):247-54. PubMed ID: 2550107 [TBL] [Abstract][Full Text] [Related]
51. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
52. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Clark D; Salah RS; Galloway MP Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667 [TBL] [Abstract][Full Text] [Related]
53. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats. Henselmans JM; Hoogland PV; Stoof JC Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666 [TBL] [Abstract][Full Text] [Related]
54. Dopamine D2 receptors attenuate phosphatidylinositol 4,5-bisphosphate in synaptosomal membranes from rat neostriatum. von Euler G; von Euler A J Neurochem; 1991 Jan; 56(1):136-40. PubMed ID: 1846171 [TBL] [Abstract][Full Text] [Related]
55. One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat. Ashby CR; Hitzemann R; Rubinstein JE; Wang RY Brain Res; 1989 Jul; 493(1):194-7. PubMed ID: 2570618 [TBL] [Abstract][Full Text] [Related]
56. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Wang HY; Undie AS; Friedman E Mol Pharmacol; 1995 Dec; 48(6):988-94. PubMed ID: 8848015 [TBL] [Abstract][Full Text] [Related]
57. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells. Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020 [TBL] [Abstract][Full Text] [Related]
58. Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney. Schmidt M; Krieger JP; Giesen-Crouse EM; Imbs JL Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):195-205. PubMed ID: 2954515 [TBL] [Abstract][Full Text] [Related]
59. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval. De Boer P; Damsma G; Schram Q; Stoof JC; Zaagsma J; Westerink BH Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):144-52. PubMed ID: 1349159 [TBL] [Abstract][Full Text] [Related]
60. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. Sesack SR; Bunney BS J Pharmacol Exp Ther; 1989 Mar; 248(3):1323-33. PubMed ID: 2564893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]